Skip to main content
. 2017 Sep 19;8(61):104552–104559. doi: 10.18632/oncotarget.21053

Table 3. Adverse Event based on CTCAE 4.0.

Adverse Event Adverse Event Grade
0 1 2 3 4 Total (n,%)
Hypertension 27 8 4 3 0 15 (35.71)
Hand-foot syndrome 25 11 5 1 0 17 (40.48)
Fatigue 36 4 2 0 0 6 (14.29)
Diarrhea 35 4 2 1 0 7 (16.67)
Pain 35 3 3 1 0 7 (16.67)
Proteinuria 37 5 0 0 0 5 (11.90)
Nausea 37 2 1 1 0 5 (11.90)
Vomiting 30 8 4 0 0 12 (28.57)
Anemia 33 7 2 0 0 9 (21.43)
Leukopenia 27 7 8 0 0 15 (35.71)
Aminotransferase
increased
23 9 7 3 0 19 (45.24)
 Thrombocytopenia 32 6 3 1 0 10 (23.81)
Neutropenia 30 7 5 0 0 12 (28.57)
Dizziness 39 3 0 0 0 3 (7.14)